Bevacizumab + Erlotinib

From OncoWiki
Revision as of 02:17, 7 February 2012 by Palmdoc (talk | contribs) (1 revision)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

Regimen

  • Bevacizumab (Avastin) 10 mg/m2 iv over 30-90 min q2w
  • Erlotinib (Tarceva) 150 mg po qd

References

Hainsworth JD et al. Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: The Minnie Pearl Cancer Research Network. J Clin Oncol 2007; 25:1747

Retrieved from "http://oncowiki.info/index.php?title=Bevacizumab_%2B_Erlotinib&oldid=91"